Skip to main content

Table 1 Baseline characteristics of the patients at baseline and with at least one clinical follow up over 2 years

From: Treatment effects of reverse total shoulder arthroplasty – a simple method to measure outcomes at 6, 12, 24 and 60 months for each patient

 

All Patients with pre-op data

Patients with follow up data

 

N = 203

N = 183

Hamada Grade

 Stage 2

55 (27.1%)

49 (26.8%)

 Stage 3

43 (21.2%)

41 (22.4%)

 Stage 4a; Stage 4b; Stage 5

105 (51.7%)

93 (50.8%)

Age

 Mean (SD)

74.9 (6.7)

74.7 (6.5)

 Range

41.9 to 91.6

41.9 to 87.5

Gender

 Female

134 (66.0%)

122 (66.7%)

 Male

69 (34.0%)

61 (33.3%)

Dominance

 Dominant

185 (91.1%)

166 (90.7%)

 Non dominant

18 (8.9%)

17 (9.3%)

ASA grade

 1

15 (7.4%)

13 (7.1%)

 2

22 (10.8%)

20 (10.9%)

 3

69 (34.0%)

66 (36.1%)

 4 and 5

97 (47.8%)

84 (45.9%)

ASES

 Mean (SD)

20.3 (12.9)

20.8 (12.8)

 Range

0.0 to 63.3

0.0 to 63.3

Constant

 Mean (SD)

24.6 (13.2)

25.3 (13.2)

 Range

3.0 to 67.0

3.0 to 67.0